None
Quote | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
Last: | $2.18 |
---|---|
Change Percent: | 0.0% |
Open: | $2.13 |
Close: | $2.18 |
High: | $2.35 |
Low: | $2.11 |
Volume: | 712,408 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
2024-07-02 12:55:12 ET More on Checkpoint Therapeutics Seeking Alpha’s Quant Rating on Checkpoint Therapeutics Historical earnings data for Checkpoint Therapeutics Financial information for Checkpoint Therapeutics Read the full article on Seeking Alp...
2024-07-02 08:07:43 ET More on Checkpoint Therapeutics Seeking Alpha’s Quant Rating on Checkpoint Therapeutics Historical earnings data for Checkpoint Therapeutics Financial information for Checkpoint Therapeutics Read the full article on Seeking Alp...
Message Board Posts | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
Subject | By | Source | When |
---|---|---|---|
$CKPT............................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g | glenn1919 | investorshub | 04/29/2023 12:50:02 PM |
$CKPT.......................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g=0&id | glenn1919 | investorshub | 04/22/2023 12:17:50 PM |
$CKPT.....................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g=0&id=p | glenn1919 | investorshub | 04/15/2023 7:26:28 PM |
This stock sure is volatile!! | vein | investorshub | 01/18/2023 2:54:08 PM |
Yeah , especially with the rise in stock price | vein | investorshub | 01/14/2023 6:05:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
Checkpoint Therapeutics Inc. Website:
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has completed the resubmission of its Biologics License Application (“BLA”) t...
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its bi...